Aiming for the future:The latest advances in targeted therapy for ovarian cancer
10.3969/j.issn.1006-5725.2024.14.001
- VernacularTitle:瞄准未来:卵巢癌靶向治疗的新进展
- Author:
Shan'gao HUANG
1
;
Yueling WU
;
Ying ZHANG
Author Information
1. 广东医科大学附属医院妇产医学中心(广东湛江 524000)
- Keywords:
ovarian cancer;
targeted rherapy;
PARP Inhibitors;
ADCs;
research progress
- From:
The Journal of Practical Medicine
2024;40(14):1901-1907
- CountryChina
- Language:Chinese
-
Abstract:
Ovarian cancer represents a significant threat to women's health globally,with particularly high recurrence and mortality rates in China's context of gynecological malignancies.The effectiveness of traditional therapeutic approaches for advanced and recurrent ovarian cancer remains quite limited.However,recent studies have highlighted the substantial success of targeted therapies in managing ovarian cancer.This paper delves into both national and international research on ovarian cancer's targeted treatments,examining their mechanisms,applications,current landscape,and the challenges they face.It aims to offer innovative perspectives and directions for ovarian cancer treatment.
